• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
FDA Keeps COVID-19 EUA Pipeline Open While Working toward Transition

FDA Keeps COVID-19 EUA Pipeline Open While Working toward Transition

by Glenn S. Demby | Mar 30, 2023 | Essential, FDA-lir, Laboratory Industry Report

HHS secretary takes action to ensure that EUAs remain in effect until the “significant potential” for a COVID-19 PHE no longer exists.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA to Keep COVID-19 EUA Pipeline Open for Now

FDA to Keep COVID-19 EUA Pipeline Open for Now

by Glenn S. Demby | Mar 29, 2023 | News, Open Content

U.S. Department of Health and Human Services secretary takes action to ensure continued access to COVID-19 EUA products.

FDA Breaks New Ground in COVID-19 & Concussion Blood Testing Approvals

FDA Breaks New Ground in COVID-19 & Concussion Blood Testing Approvals

by Glenn S. Demby | Mar 23, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

In the period from Mid-February through mid-March, three different products received first-of-their-kind clearances from the agency.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
What Happens to COVID-19 Tests after the EUA Pipeline Closes Down?

What Happens to COVID-19 Tests after the EUA Pipeline Closes Down?

by Glenn S. Demby | Feb 28, 2023 | Essential, FDA-lir, Laboratory Industry Report

Companies in the COVID-19 diagnostic products market will need to decide whether to wind down their EUA-based investments.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Special Report: What Next for COVID-19 Tests?

Special Report: What Next for COVID-19 Tests?

by Glenn S. Demby | Feb 16, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Top of the News-dtet

An overview of what will happen to the COVID-19 tests issued via EUA once the public health emergency ends on May 11.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com